Kits Enterprise Value Over E B I T D A from 2010 to 2024

KITS Stock  CAD 9.29  0.34  3.80%   
Kits Eyecare Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to grow to 110.34 this year. During the period from 2010 to 2024, Kits Eyecare Enterprise Value Over EBITDA quarterly data regression pattern had range of 227 and standard deviation of  52.87. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
105.08704861
Current Value
110.34
Quarterly Volatility
52.87055721
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kits Eyecare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kits Eyecare's main balance sheet or income statement drivers, such as Interest Income of 352.2 K, Interest Expense of 1.6 M or Selling General Administrative of 12.8 M, as well as many indicators such as Price To Sales Ratio of 0.96, Dividend Yield of 0.0 or PTB Ratio of 4.0. Kits financial statements analysis is a perfect complement when working with Kits Eyecare Valuation or Volatility modules.
  
This module can also supplement various Kits Eyecare Technical models . Check out the analysis of Kits Eyecare Correlation against competitors.

Other Information on Investing in Kits Stock

Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.